EDGAR Filing Documents for 0001404644-24-000045

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:

SEC Accession No. 0001404644-24-000045

Filing Date

2024-04-26

Accepted

2024-04-26 14:34:31

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	DEFA14A	defa14a2024agmnoticea.htm	DEFA14A	9994
2		proxynotice-final001.jpg	GRAPHIC	143625
3		proxynotice-final002.jpg	GRAPHIC	103484
	Complete submission text file	0001404644-24-000045.txt		351764

Mailing Address 535 W 24TH STREET 5TH FLOOR NEW YORK NY 10011

Business Address 535 W 24TH STREET 5TH FLOOR NEW YORK NY 10011 (877) 237-5020

Neurogene Inc. (Filer) CIK: 0001404644 (see all company filings)

IRS No.: 980542593 | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36327 | Film No.: 24882238
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)